Catalyst Pharm Inc CPRX

$31.49 +0.01 (0.03%)

Valuation

Market cap
3,855,006,000
Revenue TTM
$588,990,000
Net income TTM
$214,330,000
PE ratio
11.92
Forward PE
11.93
Profit margin
36.39%
Debt to equity
0.00

Trading

Volume
15,513,800
Avg volume
2,707,952
Day's range
$31.48 – $31.50
Shares out
122,420,000
Stochastic %K
80%
Beta
0.74
Analysts
Sell
Price target
$32.80

Price

Company profile

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropio...

Show more

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizure; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
305 420 3200
Website
https://catalystpharma.com
Address
355 Alhambra Circle, Suite 801, Coral Gables, United States

Latest news

Stocktwits

bears_blood1 Oct 22, 11:33 PM
$CMPX Catalyst Pharmaceuticals $CPRX Catalyst Pharms., Inc. v. Becerra (2021) The FDA approved a competitor's drug for a different patient population, effectively stripping Catalyst's drug Firdapse of its statutory 7-year Orphan Drug exclusivity window. Won. The 11th Circuit Court of Appeals ruled that the plain language of the Orphan Drug Act protects the drug for the entire rare disease condition, not just specific sub-populations. The FDA was forced to vacate its approval of the competing product.
0 replies
yva Oct 8, 1:42 PM
$CPRX I remember the good old days with CPRX… bought at an average of $2.60–$3.10 and sold at $31.25. It'd be over $40 now. I'm hoping to pull off the same with ARDX, but the red days still sting.
0 replies
wizeinvesting Aug 21, 8:30 AM
$CPRX Should your next extra dollar go toward paying down your mortgage or building your investment portfolio? There is no universal answer—and the old advice to simply invest instead of paying off the house doesn't work for everyone. Your mortgage rate, cash reserves, retirement contributions, taxes, liquidity, and comfort with market risk can completely change the calculation. What makes sense with a 3% mortgage may look very different with a 7% loan. A 3% mortgage and a 7% mortgage are practically two different financial decisions. One may make keeping the debt and investing more attractive, while the other can make guaranteed interest savings increasingly difficult to ignore. The bigger question isn't “Mortgage or stocks?” It's: Where can your next dollar strengthen your financial position without leaving you vulnerable when life gets unpredictable? https://www.wizeinvesting.com/p/simple-steady-effective-building-with-500-a-month-in-lly
0 replies
zorkaxo Aug 19, 7:23 PM
$CPRX would have been up 20% today easy. RIP
0 replies
KEVSTER252 Aug 14, 2:36 PM
$CPRX thinking about you today..
0 replies
WB_Bull Jul 27, 8:36 AM
$CPRX Thanks to everyone for all that professional comments. I was 14 years on that message board. My Investment is now in Santhera (SANN.SW), could be a next takeover (Owner of the Agamree Licence) . GLTA
0 replies
CH_Expat Jul 22, 1:55 PM
$CPRX @DLAT94 Anorher one I sold way too early. But the pick was good. Congrats longs!
1 replies
DeMontoire Jul 17, 10:52 PM
$CPRX we all were looking for this outcome. Been with this group for the better part of the last 10 years plus. I tank you all and I am super happy that many longs got to enjoy now the fruits of patience CPRX gave us. A good friend of mine worked at CPRX and introduced me to it when it was below $1. I can only thank him. So long all!
0 replies